Veeva Systems Inc. has made a significant stride in the life sciences sector by acquiring Copli and introducing its innovative AI-driven Medical, Legal, and Regulatory (MLR) content review platform, Veeva Falcon MLR. This strategic move aims to revolutionize how promotional and medical content is reviewed, streamlining processes and enhancing efficiency. The new platform is expected to automate a substantial portion of manual MLR tasks, thereby accelerating the dissemination of crucial information within the healthcare ecosystem and improving operational workflows for life sciences companies worldwide.
On June 23, Veeva Systems, a prominent provider of cloud-based software for the global life sciences market, officially unveiled its latest advancements. The company announced the successful acquisition of Copli, a move that immediately preceded the launch of Veeva Falcon MLR. This platform is specifically engineered to automate the intricate and often time-consuming process of reviewing medical, legal, and regulatory content. By leveraging artificial intelligence, Veeva Falcon MLR meticulously checks materials against established guidelines and local regulations, ensuring compliance and accuracy. The platform was made instantly available to clients, signaling Veeva's commitment to rapidly deploying cutting-edge solutions.
The core objective of Veeva Falcon MLR is to bring about a fundamental shift in the content review paradigm. The company projects that this AI-powered solution has the potential to eliminate over 70% of manual MLR work within the next five years. This drastic reduction in manual effort not only promises significant cost savings but also frees up human reviewers to concentrate on more complex, high-value tasks that require nuanced judgment. Jacob Scheel-Bech, CEO of Copli, emphasized the transformative nature of this launch, highlighting how the acquisition will support the expansion of Copli's AI-focused MLR vision by integrating its technology with Veeva PromoMats, an existing Veeva product.
Emma Hyland, Vice President of Veeva Commercial Content, further elaborated on the profound impact of Veeva Falcon MLR. She pointed out that traditional MLR processes have historically been a bottleneck, slowing down the delivery of vital information to both patients and physicians. By automating routine aspects of content review, Veeva Falcon MLR is set to drastically shorten review cycles. This acceleration means that critical medical and promotional content can reach its intended audience faster, improving patient access to information and supporting healthcare professionals in their practice. Veeva Systems' continuous innovation underscores its role as a leader in providing specialized software solutions for the life sciences industry across North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America.
Veeva Systems' latest initiatives, the acquisition of Copli and the launch of Veeva Falcon MLR, represent a strategic enhancement to its offerings in the life sciences sector. These developments are poised to significantly improve the efficiency and speed of medical content review, fostering quicker dissemination of information to patients and healthcare providers globally. The integration of AI technology into MLR processes underscores Veeva's dedication to innovation and its ongoing efforts to meet the evolving demands of the pharmaceutical and biotech industries.